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Catabolism of homologous low density lipoproteins (LDL) was studied in primary culture of human hepa- 
tocytes (HH). The cell association and degradation of *251-Iabeled LDL (12sI-LDL) were curvilinear func- 
tions of substrate concentration. Cell association and degradation of lzSI-LDL were inhibited by excess un- 
labeled LDL. Reductive methyIation of unlabeled LDL abolished its ability to compete with *ZSI-LDL for 
cell association and degradation. Preincubation of HH with unlabeled LDL caused a 63% inhibition of the 
1251-LDL degradation. It is concluded that the catabolism of LDL by HH proceeds in part through a recep- 
tor-mediated pathway similar to that demonstrated on extrahepatic ells. 
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1. INTRODUCTION 
In man, LDL is the major cholesterol- 
transporting lipoprotein and has been implicated 
as an independent risk factor in atherogenesis. The 
concentration of LDL in the plasma depends upon 
the rate of LDL synthesis and efficacy of their 
catabolism by different tissues of the organism. It 
has been shown that the liver plays an important 
role in this process. In several species at least one- 
third of plasma LDL are broken down in the liver 
fl,2], more than 70% of them being degraded via 
a high-affinity receptor mechanism [3]. 
The possible presence of LDL receptor activity 
has also been tested in human liver. One group of 
investigators failed to show the presence of specific 
LDL receptors on membranes of adult human liver 
(41, whereas another group reported specific LDL 
receptor activity on membrane fractions prepared 
from adult human liver biopsies [5]. These data are 
contradictory, and moreover the methodology of 
these experiments does not allow study of the in- 
tracellular metabolism of LDL by cells of human 
liver, 
This study was undertaken to investigate the 
mechanism of human hepatic LDL association and 
degradation using primary culture of hepatocytes. 
2. MATERIALS AND METHODS 
2.1. Lipoproteins 
LDL (1.019-I .063 g/ml) were isolated from the 
plasma of healthy donors by differential ultracen- 
trifugation [6]. The apoprotein composition of 
LDL fractions was determined by SDS- 
polyacrylamide gel electrophoresis f7J; they con- 
tain almost no protein other than apoprotein B. 
“‘I-LDL (spec. act. 100-300 cpm/ng LDL pro- 
tein) were prepared by the iodine monochloride 
method [8]. Reductively methylated LDL (m-LDL) 
were prepared as described [9]. 
2.2. Cells 
Right lobes of the liver were obt~ned from 4 
organ donors aged from 25 to 50 years. None was 
known to be suffering from any metabolic disease 
known to influence plasma lipoprotein metab- 
olism. HH were isolated using the two-step hepatic 
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portal vein enzymatic perfusion technique de- 
scribed previously [lo, 111; the cells were plated in 
35-mm plastic dishes at 1.6 x 10’ cells/dish in 1 ml 
RPMI-1640 medium containing 10% fetal calf 
serum (FCS), insulin (10e6 M), hydrocortisone 
(lo-* M), kanamycin (100 pg/ml), and L- 
glutamine (2 x 10e3 M). Human skin fibroblasts 
(HF) (6th-10th passages) were obtained from a 
skin biopsy of healthy donors and cells were plated 
at 1 x 10’ cells/dish in 1 ml EME medium contain- 
ing 15% FCS, 1% nonessential amino acids, 
kanamycin (100 rg/ml), L-glutamine (2 x 10e3 
M). Cells were maintained at 37°C in a humidified 
incubator under 5% CO2/95% air. HH were used 
within 2-4 days and HF within 3 days after plating. 
2.3. Measurement of LDL cell association and 
degradation 
18 h before the experiment, the culture medium 
was replaced with similar medium (1 ml/dish) con- 
taining 10% human lipoprotein-deficient serum 
(LPDS) instead of FCS. Then, 1 ml of fresh media 
and various amounts of ‘251-LDL in the presence 
or absence of either unlabeled LDL or m-LDL 
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were added to each dish. After incubation at 37°C 
for the indicated time, dishes were placed on ice 
and “‘1-LDL cell association and degradation 
were determined [12,13]. K,,, and the maximal 
number of association sites for LDL were cal- 
culated as described [141. Results for 4 studies were 
quite similar, and here we present he details from 
one study. 
3. RESULTS AND DISCUSSION 
Fig. 1A shows that curves for cell association 
(surface binding and internalization at i251-LDL) 
exhibited a biphasic nature; they did not reach a 
plateau but continued to increase up to the 100 ,ug 
protein/ml tested. In the presence of a 20-fold ex- 
cess of unlabelled LDL, the saturable component 
of the curves was abolished and only nonspecific 
association of “‘1-LDL to the cells was observed. 
The high-affinity receptor-mediated cell associa- 
tion of ‘251-LDL was calculated by subtracting the 
nonspecific cell-associated “‘1-LDL from the total 
(in the absence of unlabeled LDL) and analysed by 
a Scatchard plot (fig.lB). There was little dif- 
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Fig. 1. Saturation curves for human “‘1-LDL association toHH (0) and HF (0). (A) Cells were prepared as described 
in section 2 and incubated with increasing concentrations of 12’I-LDL in the absence (o,m) or presence (0,O) of 
20-fold excess unlabeled LDL. (B) Scatchard plots for HH (0); K,= 16.1 k 2.8, n =419 it_ 39.5; FH (o), K,=26.8 
+ 5.8, n=862.4 + 78.8. Values are means of triplicate incubations. 
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ference in K,,, and maximal number of association 
sites for LDL (n) between the two cell types. The 
K,,, of the HH for cell-associated “‘1-LDL was 
60% of HF, indicating a small increase in affinity 
for lipoproteins. The maximal number of sites (n) 
in HH was 49% of HF; they likely have half the 
number of HF receptors. 
Modification of lysine residues by reductive 
methylation has been shown to abolish the binding 
of LDL to receptors in HF [15]. To determine the 
role of lysine amino groups in human LDL binding 
to HH receptors, cell monolayers were prein- 
cubated with RPMI-1640 medium containing 10% 
LPDS for 5 h at 37°C. The medium was then 
changed to RPMI-1640 medium, containing 10% 
LPDS and 1251-LDL (5 fig protein/ml), and 
thereafter the cell association of “‘1-LDL was 
measured in the presence of excess of untreated or 
modified LDL. As shown in fig.2, reductive 
methylation of LDL completely abolishes its abili- 
ty to compete with 12’1-LDL for association. 
Incubation of HH for 18 h at 37°C with increas- 
ing concentrations of 1251-LDL demonstrated that, 
similar to cell association, degradation was a cur- 
vilinear function of substrate concentration (fig.3). 
The degradation of LDL by HH at 200pg/ml was 
0.8 pg/mg cell protein per day which corresponds 
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Fig.2. Effect of LDL (0) and m-LDL (0) on “‘1-LDL 
association with HH. HH monolayers were incubated 
for 5 h in medium containing 5 pg/ml “‘1-LDL and 
unlabelled lipoproteins at the indicated protein concen- 
trations. The ‘100% control value’ for cell-associated 
lZ51-LDL in the absence of unlabeled lipoproteins was 92 
ng/mg cell protein per 5 h. Values are means of triplicate 
of LDL (a), m-LDL (0), and preincuba- ._r 
tion with LDL (0) on “‘I-LDL degradation by HH. 
During the experiments, cells were incubated with 5 
ag/ml r2’I-LDL and in the presence or absence of in- 
creasing concentration of either unlabeled LDL or m- 
LDL. The 100% control value for “‘1-LDL degraded in 
the absence of unlabeled lipoproteins was 90 ng/mg cell 
protein per 18 h. Values are means of triplicate 
incubations. incubations. 
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Fig.3. Degradation of ‘251-LDL by HH as a function of 
concentration. Values are means of triplicate 
incubations. 
to 0.121 mg LDL protein/g liver per day. From 
studies utilizing sucrose-[14C]LDL, the rate of 
degradation of LDL by pig liver in vivo has been 
estimated to be 0.23 mg/g of liver per day [la]. 
Thus, the capacity of HH to degrade LDL is of the 
same order of magnitude as that found for the 
hepatic contribution to LDL degradation in vivo. 
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The LDL receptors in HF and other extrahepatic 
cells are down-regulated according to the uptake of 
LDL cholesterol [ 171. To determine whether HH 
receptors are similarly regulated, cells were prein- 
cubated in the presence of 10% LPDS with or 
without a high concentration of unlabeled LDL 
(100 ,ug protein/ml). After 18 h preincubation at 
37°C the medium was changed to RPMI-1640 
medium containing 10% LPDS, ‘251-LDL (5 pg 
protein/ml) and increasing concentrations of 
unlabeled LDL, and degradation was measured 
during the next 18 h. As shown in fig.4, this 
degradation by cells previously incubated with 
LDL was only about 37% of that in cells previous- 
ly incubated with LPDS. Most of the degradation 
occurred by the high-affinity receptor-mediated 
mechanism since unlabeled LDL inhibit this 
degradation. Reductive methylation of LDL com- 
pletely abolished their ability to compete with lz51- 
LDL for degradation (fig.4). 
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Thus, these data demonstrate the presence of a 
high-affinity receptor-dependent mechanism of 
LDL uptake and degradation in cultured human 
hepatocytes which is similar to the mechanism 
described for the extra hepatic cells. 
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